All Articles
PortfolioFunding
Eleos is the leader in CareOps Automation for behavioral health and joins Menlo Ventures’ exciting portfolio of healthcare software and AI companies.
PortfolioFunding
Hardening the Data Moat: Our Investment in Cleanlab
With Cleanlab, AI teams automate weeks of manual data labeling and bypass dozens of engineering hours for model training and deployment.
Firm
Menlo Welcomes Former Atlassian CPO Joff Redfern to Our Investment Team
Joff joins our team of deep and complementary operators and, in particular, adds world-class expertise in finding product-market fit and scaling product organizations.
Perspective
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world…
PerspectivePortfolio
Generative AI: Lessons From Prior Waves
While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can…
PortfolioFunding
Our Investment in Anthropic: The Foundation Layer for Generative AI
We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.
PortfolioPerspective
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
PerspectivePortfolio
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies
OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history.…
PortfolioFunding
Pinecone Now Valued at $750M, Arguably the Most Important Element in the Modern Data Stack
Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.
PortfolioPerspective
Video: Reengineering Drug Discovery With Recursion
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
PortfolioFunding
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale
Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.
PortfolioFunding
Building the Organizational Knowledge Graph: Our Series B Investment in Sana
There’s been a seismic shift in the environment for learning and training on the job.